3649 results for «414»
3649 results
Has the 2023 ESC-EACTS guideline review on left main changed my practice?
15 May 2024 – From EuroPCR 2024
Watch this session if you wish to learn why the 2019 guidelines were revised, how to apply the updated recommendations in clinical settings through case examples, and the criteria for selecting patients with left main stenosis for PCI versus CABG.
The session includes detailed presentations on...
The uncrossable lesion
16 May 2024 – From EuroPCR 2024
This session delves into the challenges of dealing with uncrossable and heavily calcified coronary lesions. It features a variety of cases showcasing the use of specialized techniques and tools, such as the excimer laser, to overcome these obstacles. The session emphasizes the importance of troubleshooting, utilizing...
When mitral valve intervention goes wrong
16 May 2024 – From EuroPCR 2024
This session examines various complications that can arise during mitral valve interventions, such as iatrogenic aortic root perforation, unexpected leakage, and other challenging scenarios. The presenters share their experiences in managing these complications and the strategies they employed to address them. The session emphasizes the importance...
TAVI Hotline: new devices, new approaches
15 May 2024 – From EuroPCR 2024
Innvolution Healthcare reports one-year findings from the ALCHEMY study evaluating Eternia in 1000 patients at EuroPCR 2026
27 May 2026
Four-Year Outcomes from the EVOLUT Low Risk Trial
26 Oct 2023
Dejan Milasinovic provides his take on the EVOLUT Low Risk trial, presented by Michael I. Reardon at TCT Congress 2023. 4-year results reveal a continuing trend towards lower combined rates of all-cause mortality and disabling stroke with TAVI compared with surgical aortic valve replacement (SAVR)
Author
5-year outcomes after transcatheter or surgical aortic valve replacement in low-risk patients with aortic stenosis (Evolut Low Risk)
01 Apr 2025
Yohei Ohno provides his takeaways from the results of the Evolut Low Risk trial which was presented by Michael J. Reardon during the ACC.25 in Chicago.
Author
Cardiac biomarkers in patients with asymptomatic severe aortic stenosis: primary biomarker analysis from the EARLY TAVR Trial
01 Apr 2025
Elad Asher provides his take on the primary biomarker analysis from the EARLY TAVR Trial presented by Brian R. Lindman at ACC.25 in Chicago.
Author
Transcatheter vs surgical aortic valve replacement in aortic stenosis patients at low surgical risk: 3-year outcomes from the Evolut Low Risk trial
05 Mar 2023
Luigi Biasco provides his take on the clinical trial presented by John K. Forrest from Yale University School of Medicine, New Haven, Connecticut, USA during the 2023 ACC/WCC annual congress held in New Orleans, Louisiana.
Author
